Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,226,772 papers from all fields of science
Search
Sign In
Create Free Account
COL-3
Known as:
COL 3
, COL-3 compound
A chemically-modified tetracycline with potential antineoplastic activity. COL-3 inhibits matrix metalloproteinases (MMPs), thereby inducing…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
CMT-3
Incyclinide
Metastat
Broader (1)
tetracycline CMT-3
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Estudo dos efeitos do bloqueio da integrina AvB3;vβ3 por uma desintegrina RGD recombinante na cicatrização de hérnia incisional em ratos
Claudio Ricardo de Oliveira
2014
Corpus ID: 80447834
Introducao: Hernia incisional (HI) e considerada uma doenca do tecido conjuntivo caracterizada pelo defeito no processo de…
Expand
Review
2012
Review
2012
EHLERS-DANLOS SYNDROME TYPE IV In Association with a ( c . 970 G > A ) Mutation in the COL 3 A 1 Gene
Marta Rebelo
,
Jandira Lima
,
J. D. Vieira
,
P. Tavares
2012
Corpus ID: 53522233
Recebido em: 20 de Setembro de 2010 Aceite em: 14 de Março de 2011 The Ehlers-Danlos syndrome type IV (EDS-IV) is a hereditary…
Expand
2007
2007
Metalloproteinase Inhibition Has Differential Effects on Alloimmunity, Autoimmunity, and Histopathology in the Transplanted Lung
S. Yoshida
,
T. Iwata
,
+9 authors
D. Wilkes
Transplantation
2007
Corpus ID: 24058647
Background. Upregulation of matrix metalloproteinases (MMPs) has been associated with chronic lung allograft rejection known as…
Expand
2007
2007
A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomes
Q. Chu
,
Bahram Forouzesh
,
+5 authors
E. Rowinsky
Investigational new drugs
2007
Corpus ID: 28134768
2005
2005
Col-3 A chemically midified tetracycline lacking anti-microbial activity - Provides cardiproprotection against ischemia/reperfusion injury reducint mitochondrial relocation of cytoplasmic cofilin and…
C. Chen-Scarabelli
,
R. Angeles
,
+7 authors
M. Scarabelli
2005
Corpus ID: 86313073
2003
2003
Gateways to clinical trials.
M. Bayés
,
X. Rabasseda
,
J. Prous
Methods and Findings in Experimental and Clinical…
2003
Corpus ID: 32643595
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the…
Expand
2002
2002
IMPROVED SURVIVAL IN RAT CECAL LIGATION AND PUNCTURE (CLP) WITH MODIFIED TETRACYCLINE COL-3 DOSED POST-INJURY: 254
Jeffrey M. Halter
,
Lucio A. Pavone
,
L. Gatto
,
Jay M. Steinberg
,
C. Lutz
,
G. Nieman
2002
Corpus ID: 75506482
2001
2001
COL-3: Another Drug That May Induce Lupus-like Photosensitivity
J. Callen
2001
Corpus ID: 73750535
Drug-induced cutaneous lupus erythematosus (CLE) usually manifests as a photosensitive eruption that appears histopathologically…
Expand
2001
2001
Phase I C linical T rial o f O ral C OL-3, a M atrix Metalloproteinas e I nhibitor, i n P atients W ith R efractory Metastatic C ancer
M. Rudek
,
W. Figg
,
+7 authors
E. Reed
2001
Corpus ID: 78836125
Purpose: This phase I clinical trial was designed to determine the maximum-tolerated dose and dose-limiting toxicities of the…
Expand